Literature DB >> 25230880

Integrative oncology: really the best of both worlds?

David H Gorski.   

Abstract

Over the past two decades there has been a growing acceptance of 'integrative oncology', also known as complementary and alternative medicine (CAM), in cancer care and research at academic medical centres and medical schools. Proponents of integrative oncology argue that it is based in science and provides the 'best of both worlds' by combining science-based treatments and 'holistic' medicine. However, a close examination of the methodologies indicates that, from a standpoint of basic science, the vast majority of 'integrative' treatments are supported by little, if any, scientific evidence. What are the consequences of this integration? Is there any harm? Are there any potential benefits?

Entities:  

Mesh：

Year:  2014        PMID： 25230880     DOI： 10.1038/nrc3822

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN： 1474-175X            Impact factor:   60.716


  153 in total

1.  Re-analysis of previous meta-analysis of clinical trials of homeopathy.

Authors:  E Ernst; M H Pittler
Journal:  J Clin Epidemiol       Date:  2000-11       Impact factor: 6.437

2.  Improving validation practices in "omics" research.

Authors:  John P A Ioannidis; Muin J Khoury
Journal:  Science       Date:  2011-12-02       Impact factor: 47.728

Review 3.  The truth about homeopathy.

Authors:  E Ernst
Journal:  Br J Clin Pharmacol       Date:  2007-09-13       Impact factor: 4.335

Review 4.  Chiropractic: a critical evaluation.

Authors:  Edzard Ernst
Journal:  J Pain Symptom Manage       Date:  2008-02-14       Impact factor: 3.612

5.  True and sham acupuncture produced similar frequency of ovulation and improved LH to FSH ratios in women with polycystic ovary syndrome.

Authors:  Lisa M Pastore; Christopher D Williams; Jeffrey Jenkins; James T Patrie
Journal:  J Clin Endocrinol Metab       Date:  2011-08-03       Impact factor: 5.958

Review 6.  Acupuncture for cancer-related fatigue: a systematic review of randomized clinical trials.

Authors:  Paul Posadzki; Tae-Woong Moon; Tae-Young Choi; Tae-Yong Park; Myeong Soo Lee; Edzard Ernst
Journal:  Support Care Cancer       Date:  2013-02-24       Impact factor: 3.603

7.  A randomized trial of tai chi for fibromyalgia.

Authors:  Chenchen Wang; Christopher H Schmid; Ramel Rones; Robert Kalish; Janeth Yinh; Don L Goldenberg; Yoojin Lee; Timothy McAlindon
Journal:  N Engl J Med       Date:  2010-08-19       Impact factor: 91.245

8.  Adenosine A1 receptors mediate local anti-nociceptive effects of acupuncture.

Authors:  Nanna Goldman; Michael Chen; Takumi Fujita; Qiwu Xu; Weiguo Peng; Wei Liu; Tina K Jensen; Yong Pei; Fushun Wang; Xiaoning Han; Jiang-Fan Chen; Jurgen Schnermann; Takahiro Takano; Lane Bekar; Kim Tieu; Maiken Nedergaard
Journal:  Nat Neurosci       Date:  2010-05-30       Impact factor: 24.884

9.  Why the NIH Trial to Assess Chelation Therapy (TACT) should be abandoned.

Authors:  Kimball C Atwood; Elizabeth Woeckner; Robert S Baratz; Wallace I Sampson
Journal:  Medscape J Med       Date:  2008-05-13

Review 10.  Complementary or alternative medicine in cancer care-myths and realities.

Authors:  Gary Deng; Barrie Cassileth
Journal:  Nat Rev Clin Oncol       Date:  2013-07-30       Impact factor: 66.675
View more
  11 in total

Review 1.  Complementary and Alternative Therapies in Amyotrophic Lateral Sclerosis.

Authors:  Richard S Bedlack; Nanette Joyce; Gregory T Carter; Sabrina Paganoni; Chafic Karam
Journal:  Neurol Clin       Date:  2015-09-08       Impact factor: 3.806

2.  Growth inhibitory efficacy of natural products in a model for triple negative molecular subtype of clinical breast cancer.

Authors:  Nitin Telang
Journal:  Biomed Rep       Date:  2017-08-01

Review 3.  Efficacy and Mechanisms of Aerobic Exercise on Cancer Initiation, Progression, and Metastasis: A Critical Systematic Review of In Vivo Preclinical Data.

Authors:  Kathleen A Ashcraft; Ralph M Peace; Allison S Betof; Mark W Dewhirst; Lee W Jones
Journal:  Cancer Res       Date:  2016-07-05       Impact factor: 12.701

4.  Health services research of integrative oncology in palliative care of patients with advanced pancreatic cancer.

Authors:  Jan Axtner; Megan Steele; Matthias Kröz; Günther Spahn; Harald Matthes; Friedemann Schad
Journal:  BMC Cancer       Date:  2016-08-02       Impact factor: 4.430

Review 5.  Epigenetic Mechanisms of Integrative Medicine.

Authors:  Riya R Kanherkar; Susan E Stair; Naina Bhatia-Dey; Paul J Mills; Deepak Chopra; Antonei B Csoka
Journal:  Evid Based Complement Alternat Med       Date:  2017-02-21       Impact factor: 2.629

6.  Chinese Herbal Medicine Effectively Prolongs the Overall Survival of Pancreatic Cancer Patients: A Case Series.

Authors:  Wendy Wong; Bing Zhong Chen; Allyson Kin Yan Lee; Adrian Ho Cheung Chan; Justin Che Yuen Wu; Zhixiu Lin
Journal:  Integr Cancer Ther       Date:  2019 Jan-Dec       Impact factor: 3.279

7.  Micronutrients and the Immune System: Some Is Good but We Need to Know More.

Authors:  Henry J Thompson
Journal:  Nutrients       Date:  2021-01-20       Impact factor: 5.717

8.  Complementary and alternative medicine use by glioma patients in Switzerland.

Authors:  Günter Eisele; Ulrich Roelcke; Katrin Conen; Fabienne Huber; Tobias Weiss; Silvia Hofer; Oliver Heese; Manfred Westphal; Caroline Hertler; Patrick Roth; Michael Weller
Journal:  Neurooncol Pract       Date:  2018-10-12

9.  On/off-switchable anti-neoplastic nanoarchitecture.

Authors:  Hirak K Patra; Roghayeh Imani; Jaganmohan R Jangamreddy; Meysam Pazoki; Aleš Iglič; Anthony P F Turner; Ashutosh Tiwari
Journal:  Sci Rep       Date:  2015-09-29       Impact factor: 4.379

Review 10.  Combination therapy for metastatic melanoma: a pharmacist's role, drug interactions & complementary alternative therapies.

Authors:  Gabriel Gazzé
Journal:  Melanoma Manag       Date:  2018-06-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.